FRUSCIO, ROBERT
 Distribuzione geografica
Continente #
NA - Nord America 17.125
EU - Europa 8.283
AS - Asia 4.632
SA - Sud America 308
AF - Africa 51
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 24
Totale 30.462
Nazione #
US - Stati Uniti d'America 16.811
IT - Italia 2.048
CN - Cina 1.583
SG - Singapore 1.383
IE - Irlanda 1.164
DE - Germania 1.003
SE - Svezia 928
RU - Federazione Russa 883
HK - Hong Kong 716
UA - Ucraina 633
GB - Regno Unito 443
CA - Canada 261
ID - Indonesia 255
FI - Finlandia 225
BR - Brasile 198
FR - Francia 197
AT - Austria 156
TR - Turchia 152
IN - India 140
VN - Vietnam 136
NL - Olanda 129
ES - Italia 94
DK - Danimarca 89
JP - Giappone 69
BE - Belgio 62
MX - Messico 44
CO - Colombia 40
CH - Svizzera 39
AU - Australia 32
PT - Portogallo 31
IR - Iran 30
PL - Polonia 28
TH - Thailandia 26
CZ - Repubblica Ceca 24
EG - Egitto 22
PH - Filippine 21
SK - Slovacchia (Repubblica Slovacca) 20
RO - Romania 19
PE - Perù 18
CL - Cile 17
GR - Grecia 17
KR - Corea 16
BG - Bulgaria 15
EU - Europa 15
VE - Venezuela 13
IL - Israele 12
AR - Argentina 10
LV - Lettonia 10
TW - Taiwan 9
A2 - ???statistics.table.value.countryCode.A2??? 8
MA - Marocco 8
SA - Arabia Saudita 8
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
BD - Bangladesh 5
EC - Ecuador 5
IQ - Iraq 5
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
RS - Serbia 5
UZ - Uzbekistan 5
AL - Albania 4
BO - Bolivia 4
ET - Etiopia 4
AZ - Azerbaigian 3
CY - Cipro 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
MD - Moldavia 3
UY - Uruguay 3
ZA - Sudafrica 3
FJ - Figi 2
GE - Georgia 2
LT - Lituania 2
LU - Lussemburgo 2
MW - Malawi 2
MZ - Mozambico 2
OM - Oman 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 30.454
Città #
Ann Arbor 3.294
Woodbridge 1.570
Fairfield 1.493
Dublin 1.110
Houston 1.061
Singapore 950
Chandler 948
Ashburn 869
Wilmington 815
Jacksonville 688
Hong Kong 687
Seattle 636
Frankfurt am Main 581
Cambridge 518
Dearborn 488
New York 469
Santa Clara 468
Milan 463
Princeton 426
Jakarta 248
Hangzhou 220
Nanjing 208
Lawrence 191
Altamura 170
Beijing 169
Shanghai 161
Boardman 156
Vienna 118
Lachine 112
San Diego 102
Helsinki 84
Lissone 83
Nuremberg 80
Nanchang 77
Rome 74
Guangzhou 70
Council Bluffs 67
Andover 62
Ottawa 62
Dong Ket 56
London 55
Shenyang 54
Fremont 52
Los Angeles 51
Toronto 46
Hebei 44
Brussels 40
Chicago 39
Dallas 39
Changsha 38
Falls Church 34
Jinan 34
Kunming 34
Istanbul 32
Norwalk 31
Jiaxing 28
Tianjin 28
Pune 27
Huizen 25
Florence 23
Bologna 22
Monza 21
Redmond 21
Zhengzhou 21
Hefei 20
Lappeenranta 20
Munich 20
Bratislava 19
Madrid 19
Padova 19
Brescia 18
São Paulo 18
Amsterdam 16
Barcelona 16
Brno 16
Carate Brianza 16
Ankara 15
Desio 15
Mountain View 15
Naples 15
Avellino 14
Edmonton 14
Ningbo 14
Washington 14
Leawood 13
San Mateo 13
Turin 13
Verona 13
Bonndorf 12
Chengdu 12
Melbourne 12
Paris 12
Shenzhen 12
Taizhou 12
Tokyo 12
Bangkok 11
Cairo 11
Kilburn 11
Lanzhou 11
San Francisco 11
Totale 21.467
Nome #
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 661
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 474
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 373
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 352
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 329
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 313
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 298
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 294
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 293
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 278
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 254
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 251
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 235
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 233
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 217
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 216
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 215
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 210
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 209
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 208
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 207
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancy 203
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 203
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 200
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 196
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 196
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 195
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 194
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 194
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 193
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 191
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 191
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 189
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 187
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 186
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 185
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 184
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 184
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 182
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 181
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 181
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 179
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 177
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 175
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 171
Managing Ovarian tumors during pregnancy 170
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 170
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 169
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 168
Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa 167
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 166
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 166
PRL-3 phosphatase is implicated in ovarian cancer growth 164
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 163
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 163
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 162
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 162
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 161
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 160
The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer 159
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 156
Synchronous early-stage endometrial and ovarian cancer 153
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 153
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts 153
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 152
Delaying surgery for patients with a previous SARS-CoV-2 infection 151
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 148
Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumour Analysis) 4 cohort 145
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 145
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 142
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 142
Melanoma during pregnancy: A report of 60 pregnancies complicated by melanoma 142
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 142
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 141
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 141
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 139
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 139
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition 136
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 135
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers 135
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 134
Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy 134
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 133
Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group 132
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 131
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery 130
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 130
Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer 130
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 129
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities 129
Prognosis of patients with cervical cancer diagnosed during pregnancy 129
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 129
Harmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer 127
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors 127
The role of transvaginal ultrasound in the workup of invasive molar disease 127
The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer 126
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 126
Somministrazione settimanale di cisplatino in pazienti con carcinoma ovarico in stadio avanzato: risultati a lungo termine di uno studio clinico randomizzato 125
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 125
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study 125
Totale 18.575
Categoria #
all - tutte 126.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.178 0 0 0 0 0 0 0 0 507 256 280 135
2020/20214.136 224 177 332 423 326 355 427 496 374 424 226 352
2021/20222.629 205 226 211 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/20255.856 583 1.228 523 532 901 610 604 537 338 0 0 0
Totale 31.704